Please login to the form below

Understanding the authentic patient experience can redefine the success of your clinical trial before you design it

. Su contributes our experience are Origins that there is a willingness within the Pharmaceutical Industry to change attitudes towards clinical trial populations – making them less about academic and clinical outcomes and more inclusive of patient experience and priorities.

This month’s edition of PME features a number of articles and opinion pieces on diversity and inclusion in clinical trials. Our Director, Su Smith was interviewed as part of a featured article by Danny Buckland examining the changing tides in clinical trials. Danny highlights in the piece that though there are 1,518 COVID-19 studies registered on clinicaltrials.gov, less than 0.3% are collecting data on ethnicity. Su contributes our experience are Origins that there is a willingness within the Pharmaceutical Industry to change attitudes towards clinical trial populations – making them less about academic and clinical outcomes and more inclusive of patient experience and priorities. Origins contribute to this changing attitude by helping our pharmaceutical and medical clients to understand the authentic patient experience. This can help to design more patient-centric clinical trials where the trial participants are more representative of the true patient population (and not just the easiest to access), secondary outcomes are inclusive of patient priority and trial materials and communication are written using the lexicon of those that experience the condition and not academics that have defined it.

Read more about how understanding the authentic patient experience can redefine the success of your clinical trial before you design it here: https://origins-insights.com/understanding-the-authentic-patient-experience-can-redefine-the-success-of-your-clinical-trial-before-you-design-it/

Check out this month’s edition of PME for more insights and information: http://www.pmlive.com/pme#/reader/39369/116737

28th June 2021

Share

Tags

Company Details

Origins Insights

01252 240200

Contact Website

Address:
One Fleet
Ancells Road
Fleet
Hampshire
GU51 2UN
United Kingdom

Latest content on this profile

Understanding the authentic patient experience can redefine the success of your clinical trial before you design it
. Su contributes our experience are Origins that there is a willingness within the Pharmaceutical Industry to change attitudes towards clinical trial populations – making them less about academic and clinical outcomes and more inclusive of patient experience and priorities.
Origins Insights
RESONANT GROUP APPOINTS STEPHEN MARCHANT CHIEF DEVELOPMENT OFFICER
Stephen Marchant has joined Resonant Group in the newly created role of Chief Development Officer.  He will be working with the Board to create, grow and acquire businesses and services to support changing client needs, as well as developing new approaches to the identification, support and recruitment of a diverse team of people to deliver real change in the healthcare communications sector. Anna Korving has also joined Resonant Group as a part-time non-executive director and advisor to the Board.
Origins Insights
Origins Insights nominated for two EVCOM Clarion Awards
Origins Insights excited to have our 'What One Thing...?' RDD film shortlisted for two awards!
Origins Insights
Origins Insights wins the “Best Patient-Centric Approach” award at the BHBIA BOBI Awards 2021
Origins Insights thrilled to be named as winners at the BHBIA BOBI Awards 2021
Origins Insights
Why we need to look at rare diseases in a different way
28 February 2021, Rare Disease Day aims to raise awareness of rare diseases and the impact they have on patients’ lives.
Origins Insights